19F NMR monitoring ofin vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridine

This publication has 15 references indexed in Scilit:

• Biochemical modulation of 5-fluorouracil with brequinar: results of a phase I study
  Cancer Chemotherapy and Pharmacology, 1995
• Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.
  Journal of Clinical Oncology, 1992
• Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo
  British Journal of Cancer, 1992
• Clinical relevance of biochemical modulation of 5-fluorouracil
  Annals of Oncology, 1991
• Multinuclear MR investigation of the metabolic response of the murine RIF‐1 tumor to 5‐fluorouracil chemotherapy
  Magnetic Resonance in Medicine, 1991
• In vivo monitoring of changes in 5-fluorouracil metabolism induced by methotrexate measured by19F NMR spectroscopy
  Magnetic Resonance in Medicine, 1991
• Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo
  British Journal of Cancer, 1989
• Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate.
  Journal of Clinical Oncology, 1984
• Effect of 5-benzylacyclouridine, a potent inhibitor of uridine phosphorylase, on the metabolism of circulating uridine by the isolated rat liver
  Biochemical Pharmacology, 1983
• 5-Benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase
  Biochemical Pharmacology, 1982